The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
more
Refresh
No presentations found
We’ll display presentations we find for Medicines Company here